期刊文献+

血尿酸水平与2型糖尿病周围神经病变的相关性 被引量:7

Correlation ship of serum uric acid with type 2 diabetic peripheral neuropathy
原文传递
导出
摘要 目的探讨2型糖尿病患者血尿酸水平与糖尿病周围神经病变(DPN)之间的相关性。方法 148例住院的2型糖尿病患者,根据是否合并DPN分为单纯2型糖尿病组(A组)82例,糖尿病周围神经病变组(B组)66例,所有患者均测量体质量指数(BMI)、血尿酸(SUA)、空腹血糖(FPG)、血脂、超敏C反应蛋白(CRP),糖化血红蛋白(HbA1c)等,采用神经缺陷评分(NDS)方法判断有无DPN。结果 B组的SUA、糖尿病病程、CRP、甘油三酯(TG)明显高于A组,相关分析表明SUA与NDS评分之间呈明显正相关(r=0.723,P<0.01)。结论血尿酸与2型糖尿病周围神经病变密切相关,血尿酸是否参与糖尿病周围神经病变的发病有待进一步研究。 Objective To investigate the correlation of serum uric acid with type 2 diabetic peripheral neuropathy. Methods One hundred and forty-eight type 2 diabetic patients were derided into group A (82 diabetic patients without peripheral neuropathy) and group B (66 diabetic patients with peripheral neuropathy). The serum uric acid (SUA) and biochemical indi- cators were examined, peripheral neuropathy was diagnosed by the neuropathy disability score (NDS). Results Patients in group B showed higher SUA, diabetes duration, CRP, TG than patients in group A, and SUA was positively correlated with NDS (r = 0. 723, P 〈 0. 01 ). Conclusion SUA is closely correlated with type 2 diabetic peripheral neuropathy, whether SUA is in- volved in the pathogenesis of T2DM peripheral neuropathy remains to be studied.
作者 辛苏萍 张磊
出处 《临床医学》 CAS 2012年第9期26-27,共2页 Clinical Medicine
关键词 2型糖尿病 血尿酸 糖尿病周围神经病变 Type 2 diabetes Serum uric acid Diabetic peripheral neuropathy
  • 相关文献

参考文献5

二级参考文献20

  • 1t3enaron DA, Bowen Fw. Variation of initial serum bilirubin rise in newborn infants with type of illness. Lancet, 1991, 338:78 81.
  • 2American Diabetes Association Standards of Medical Care in Diabetes-2009. Diabetes Care, 2009,32: S13-S61.
  • 3Valensi P, Giroux C, Seeboth-Ghalayini B, et al. Diabetic peripheral neuropathy: Effects of age, duration of diabetes, glycemic control, and vascular factors. Diabetes Complications, 1997, 11: 27-34.
  • 4Evans JL, Goldfine ID, Maddux BA, et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev, 2002, 23: 599-622.
  • 5Slow RC, Sato H, Mann GE. Heme oxygenase carbon monoxide signaling pathway in atherosclerosis: antiatherogeniogenic actions of bilirubin and carbon monoxide . Cardiovasc Res, 1999, 41:385-394.
  • 6Rith-Najarian S,Branchaud C,Beaulieu O,et al.Reducing lowerextremity amputations due to diabetes.Application of the staged diabetes management approach in a primary care setting.J Fam Pract,1998,47:127-132.
  • 7Lavery LA,Wunderlich RP,Tredwell JL.Disease management for the diabetic foot:effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations.Diabetes Res Clin Pract,2005,70:31-37.
  • 8Young M J,Boulton A J,Mac Leod AF,et al.A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.Diabetologia,1993,36:150-154.
  • 9Feldman EL,Stevens MJ,Thomas PK,et al.A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.Diabetes Care,1994,17:1281-1289.
  • 10Dimitrakoudis D,Bril V.Comparison of sensory testing on different toe surfaces:implications for neuropathy screening.Neurology,2002,59:611-613.

共引文献179

同被引文献80

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部